Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder
Wedi'i Gadw mewn:
Becker, W.C., et al., Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Journal of Substance Abuse Treatment, vol. 48, 2015, p. 128-131.
Ref.
500581
Lleoliad:
SIIS R.991 Archivo
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento médico, Reducción de daños, Programas de mantenimiento, Buprenorfina, Efectos, Dolor
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento médico, Reducción de daños, Programas de mantenimiento, Buprenorfina, Efectos, Dolor
Eitemau Tebyg: Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder
- PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK
- THRICE WEEKLY SUPERVISED DOSING WITH THE COMBINATION BUPRENORPHINE-NALOXONE TABLET IS PREFERRED TO DAILY SUPERVISED DOSING BY OPIOID-DEPENDET HUMANS
- The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
- Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone
- EFFECTS OF BUPRENORPHINE AND NALOXONE IN MORPHINE-STABILIZED OPIOID ADDICTS
- Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids